The impact of COPD on quality of life, productivity loss, and resource use among the elderly united states workforce

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 9, Issue 1, 2012, Pages 46-57

  Dacosta Dibonaventura, Marco ^a   Paulose Ram, Ryne ^b   Su, Jun ^c   McDonald, Margaret ^b   Zou, Kelly H ^b   Wagner, Jan Samuel ^a   Shah, Hemal ^c  

^a KANTAR HEALTH   (United States)

^b PFIZER INC   (United States)

^c BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

Author keywords

Activities of Daily Living; Chronic Obstructive Pulmonary Disease; Quality of Life; Resource Use; Work Productivity

Indexed keywords

ABSENTEEISM; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DEMOGRAPHY; EDUCATIONAL STATUS; FEMALE; HEALTH; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PRODUCTIVITY; QUALITY OF LIFE; SMOKING; SOCIAL STATUS; UNITED STATES;

ABSENTEEISM; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COMORBIDITY; CROSS-SECTIONAL STUDIES; EFFICIENCY, ORGANIZATIONAL; EMERGENCY SERVICE, HOSPITAL; EMPLOYMENT; FEMALE; HEALTH SURVEYS; HOSPITALIZATION; HUMANS; MALE; MULTIVARIATE ANALYSIS; OFFICE VISITS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; UNITED STATES;

EID: 84856595277     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.3109/15412555.2011.634863     Document Type: Article

References (33)

1. Gold PM. The 2007 GOLD Guidelines: a comprehensive care framework. Respir Care 2009; 54:1040-9.
2. Yeo J, Karimova G, Bansal S. Co-morbidity in older patients with COPD-its impact on health service utilisation and quality of life, a community study. Age Ageing 2006; 35(1):33-7. (Pubitemid 43124918)
3. Carrasco Garrido P, de Miguel Diez J, Rejas Gutierrez J, Centeno AM, Gobartt Vazquez E, Gil de Miguel A, Garcia Carballo M, Jimenez Garcia R. Negative impact of chronic obstructive pulmonary disease on the health-related quality of life of patients. Results of the EPIDEPOC study. Health Qual Life Outcome 2006; 4:31.
4. Ståhl E, Lindberg A, Jansson SA, Rönmark E, Svensson K, Andersson F, Löfdahl CG, Lundbäck B. Health-related quality of life is related to COPD disease severity. Health Qual Life Outcom 2005; 3:56.
5. Minkoff NB. Analysis of the current care model of the COPD patient: a health outcomes assessment and economic evaluation. J Manag Care Pharm 2005; 11:S3-7; quiz S20-2.
6. Sin DD, Stafinski T, Ng YC, Bell NR, Jacobs P. The impact of chronic obstructive pulmonary disease on work loss in the United States. Am J Respir Crit Care Med 2002; 165:704-7. (Pubitemid 34194761)
7. Halpern MT, Polzin J, Higashi MK, Bakst A. The workplace impact of acute exacerbations of chronic bronchitis (AECB); A literature review. COPD 2004; 1:249-54.
8. Renwick DS, Connolly MJ. Impact of obstructive airways disease on quality of life in older adults. Thorax 1996; 51(5):520-5. (Pubitemid 26160474)
9. Sanchez FF, et al., Sanchez FF, Faganello MM, Tanni SE, Lucheta PA, Padovani CR, Godoy I. Braz J Med Biol Res 2008; 41(10):860-5.
10. Ketelaars CA, Schlösser MA, Mostert R, Huyer Abu-Saad H, Halfens RJ, Wouters EF. Determinants of health-related quality of life in patients with chronic obstructive pulmonary disease. Thorax 1996; 51(1):39-43. (Pubitemid 26048724)
11. Carrasco-Garrido P, de Miguel-Diez J, Rejas-Gutierrez J, Martin-Centeno A, Gobartt-Vazquez E, Gil de Miguel A, Jimenez-Garcia R. Characteristics of chronic obstructive pulmonary disease in Spain from a gender perspective. BMC Pulm Med 2009; 9:12.
12. Jones PW, Agusti AG. Outcomes and markers in the assessment of chronic obstructive pulmonary disease. Eur Respir J 2006; 27(4):822-32. (Pubitemid 44914209)
13. Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic obstructive pulmonary disease surveillance-United States, 1971-2000. Respir Care 2002; 47(10):1184-99.
14. Druss BG, Marcus SC, Olfson M, Pincus HA. The most expensive medical conditions in America. Health Aff (Millwood) 2002; 21(4):105-11.
15. Darkow T, Kadlubek PJ, Shah H, Phillips AL, Marton JP. A retrospective analysis of disability and its related costs among employees with chronic obstructive pulmonary disease. J Occup Environ Med 2007;49(1):22-30. (Pubitemid 46095587)
16. United States Department of Labor. Highlight of womens earnings in 2008. United States Bureau of Labor Statistics. Report 1017, 2009.
17. Bolge SC, Doan JF, Kannan H, Baran RW. Association of insomnia with quality of life, work productivity, and activity impairment. Qual Life Res 2009; 18(4):415-22.
18. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic co-morbidity in longitudinal studies: development and validation. J Chron Dis 1987; 40(5):373-83. (Pubitemid 17055592)
19. Ware JE, Kosinski M, Turner-Bowker DM, Gandek B. How to Score Version 2 of the SF-12® Health Survey (With a Supplement Documenting Version 1). QualityMetric 2002: Lincoln, RI.
20. Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics 1993; 4(5):353-65.
21. Ståhl E, Jansson SA, Jonsson AC, Svensson K, Lundbäck B, Andersson F. Health-related quality of life, utility, and productivity outcomes instruments: ease of completion by subjects with COPD. Health Qual Life Outcomes 2003; 1:18.
22. Wahlqvist P, Karlsson M, Johnson D, Carlsson J, Bolge SC, Wallander MA. Relationship between symptom load of gastro-oesophageal reflux disease and health-related quality of life, work productivity, resource utilization and concomitant diseases: survey of a US cohort. Aliment Pharmacol Ther 2008; 27(10):960-70. (Pubitemid 351537653)
23. Dean BB, Crawley JA, Schmitt CM, Wong J, Ofman JJ. The burden of illness of gastro-oesophageal reflux disease: impact on work productivity. Aliment Pharmacol Ther 2003; 17(10):1309-17. (Pubitemid 36693732)
24. DiBonaventura MD, Wagner JS, Yuan Y, LItalien G, Langley P, Kim WR. The impact of hepatitis C on labor force participation, absenteeism, presenteeism and non-work activities. J Med Econ 2011; 14(2):253-61.
25. Soriano JB, Davis KJ, Coleman B, Visick G, Mannino D, Pride NB. The proportional venn diagram of obstructive lung disease. Chest 2003; 124(2):474-81.
26. Sullivan PW, Ghushchyan VH, Slejko JF, Belozeroff V, Globe DR, Lin SL. The burden of adult asthma in the United States: evidence from the Medical Expenditure Panel Survey. J Allergy Clin Immunol 2011; 127(2):363-69.
27. Isoaho R, Puolijoki H, Huhti E, Kivelä SL, Laippala P, Tala E. Prevalence of chronic obstructive pulmonary disease in elderly Finns. Respir Med 1994; 88(8):571-80. (Pubitemid 24296917)
28. Kaplan RM. The minimally clinically important difference in generic utility-based measures. COPD: J Chron Obstruct Pulmon Dis 2005; 2(1):91-97. (Pubitemid 40776228)
29. Katsura H, Yamada K, Wakabayashi R, Kida K. Gender-associated differences in dyspnoea and health-related quality of life in patients with chronic obstructive pulmonary disease. Respirology 2007; 12(3):427-32. (Pubitemid 47164778)
30. Shaya FT, Maneval MS, Gbarayor CM, Sohn K, Dalal AA, Du D, Scharf SM. Burden of COPD, asthma, and concomitant COPD and asthma among adults: racial disparities in a medicaid population. Chest 2009; 136(2):405-11.
31. Viejo-Banuelos JL, Pueyo-Bastida A, Fueyo-Rodriguez A. Characteristics of outpatients with COPD in daily practice: The E4 Spanish project. Respir Med 2006; 100(12):2137-43. (Pubitemid 44718398)
32. Mannino DM, Braman S. The epidemiology and economics of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2007; 4(7):502-6. (Pubitemid 47547843)
33. Blanchette CM, Gutierrez B, Ory C, Chang E, Akazawa M. Economic burden in direct costs of concomitant chronic obstructive pulmonary disease and asthma in a Medicare Advantage population. J Manag Care Pharm 2008; 14(2):176-85. (Pubitemid 351453818)